| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5143231 | Current Opinion in Chemical Biology | 2017 | 9 Pages |
Abstract
Various studies have shown the beneficial effects of probiotics in humans. The use of synthetic biology to engineer programmable probiotics that specifically targets cancer, infectious agents, or other metabolic diseases has gained much interest since the last decade. Developments made in synthetic probiotics as therapeutics within the last three years will be discussed in this review.
Related Topics
Physical Sciences and Engineering
Chemistry
Chemistry (General)
Authors
Koon Jiew Chua, Wee Chiew Kwok, Nikhil Aggarwal, Tao Sun, Matthew Wook Chang,